Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of bOPV Bio Farma with Pentabio and IPV in Indonesian Infants
NCT03310073Phase 4Completed
- Sponsor
- Bio Farma
- Start
- Jul 2016
- Primary completion
- Mar 2017
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of bivalent oral poliovirus vaccine in poliomyelitis, sponsored by Bio Farma. Started Jul 2016; status: completed.
02
Drugs
bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03310073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310073.